Meissner Corporation, a company involved in advanced microfiltration and therapeutic manufacturing systems for the development and manufacture of pharmaceuticals, therapeutics, biologics, and cell and gene therapies, will invest nearly $250 million in a new manufacturing facility in Athens-Clarke County, Georgia.

The project will create more than 1,700 new jobs over the next eight years.

Meissner’s new facility will be located at the Christian Industrial Tract, located at 1310 Spring Valley Road, in Winterville. When complete, the new campus will more than double the company’s manufacturing footprint in the U.S. as the company expands its current operations.

The new site is expected to consist of multiple structures, which will include state-of-the-art cleanroom facilities, laboratories, research and development, and office spaces.

Operations are expected to begin in early 2026. The company will be hiring for a broad range of roles including technicians, scientists and engineers, as well as information technology and administrative positions.

In addition, the company plans to work with the University System of Georgia and the Technical College System of Georgia, including schools such as the University of Georgia, Georgia Institute of Technology, and Athens Technical College. These partnerships will explore potential internship and other collaboration opportunities through relevant programs of study.

“We are thrilled to embark on this important expansion and are excited to build our second U.S. manufacturing campus in Athens-Clarke County,” said Christopher Meissner, president of Meissner. “The State of Georgia, and Athens-Clarke County in particular, is an ideal location with an incredible talent pool and strong geographic position that allows us to serve clients on the East Coast and throughout the world. We sincerely appreciate the partnership with state and county officials and are eager to break ground to join the community in Athens-Clarke County.”